TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20631491

Group type: EXPERIMENTAL
Intervention: SALB (0.06 microg/kg/min iv from 0 to 60 min)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: SALB (0.06 microg/kg/min iv from 0 to 60 min) + AG (1.0 microg/kg/min iv from ‐60 to 60 min)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Isotonic saline
Number of subjects: 6
Study: 18946667

Group type: EXPERIMENTAL
Intervention: Lemon juice (60 mEq/day, approximately 85 cc/day)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Potassium citrate (60 mEq/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Dietary recommendations
Number of subjects: 30
Study: 16211207

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Metoprolol tartrate
Number of subjects: 20
Study: 11802748

Group type: COMPARATOR
Intervention: 5-day treatment with 3 antibiotics (amoxicillin 1 g bid, clarithromycin 250 mg bid, metronidazole 400 mg bid) and lansoprazole 30 mg bid (L5)
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: 3-day antibiotic-lansoprazole combination (L3) with a 2-day pretreatment with lansoprazole
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: 5-day treatment with 3 antibiotics and ranitidine hydrochloride 300 mg bid (R5)
Number of subjects: 243
Study: 10621929

Group type: EXPERIMENTAL
Intervention: Herbal remedy (Radix echinaceae, Radix baptisiae, Herba thujae), 3 tablets t.i.d. for 7 to 9 days
Number of subjects: 263

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 263
Study: 8565486

Group type: EXPERIMENTAL
Intervention: Empty patch
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sodium lauryl sulfate (SLS) and hydrochloric acid (HCl)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Nonanoic acid (NON)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Imipramine (IMI) 2.5%
Number of subjects: 8
Study: 1955502

Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol (EE; 100 ng/kg.day) after 1 week
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol (EE; 100 ng/kg.day) after 5 weeks
Number of subjects: 9

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 9
Study: 6874890

Group type: EXPERIMENTAL
Intervention: 200 mg testosterone enanthate
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 400 mg testosterone enanthate
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Testosterone treatment
Number of subjects: 6
Study: 31072850

Group type: EXPERIMENTAL
Intervention: 6-month supervised multimodal exercise programme combined with omega-3 fatty acid, vitamin D and protein supplementation
Number of subjects: 148

Group type: COMPARATOR
Intervention: Stretching/flexibility exercise programme combined with placebo supplements
Number of subjects: 148
Study: 29863974

Group type: EXPERIMENTAL
Intervention: Hyperfractionated cyclophosphamide (hyper‐C)
Number of subjects: 787

Group type: COMPARATOR
Intervention: Standard dose of cyclophosphamide
Number of subjects: 787
Study: 28004008

Group type: EXPERIMENTAL
Intervention: Prediabetes
Number of subjects: 593

Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 593

Group type: EXPERIMENTAL
Intervention: Phase 1 prediabetics
Number of subjects: 593

Group type: EXPERIMENTAL
Intervention: Age, family history of diabetes, and gender
Number of subjects: 593

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 593

Group type: EXPERIMENTAL
Intervention: Type 2 diabetes
Number of subjects: 593
Study: 24770501

Group type: EXPERIMENTAL
Intervention: Three sessions of 1540nm fractional Erbium laser (50 mJ/mB, 15ms, 2 passes)
Number of subjects: 18

Group type: COMPARATOR
Intervention: One session of 2940nm Erbium laser (5mJ/mB, 0.25ms, 2 passes)
Number of subjects: 18

Group type: COMPARATOR
Intervention: One session of 2940nm Erbium laser
Number of subjects: 18
Study: 23281754

Group type: EXPERIMENTAL
Intervention: Sodium hydrosulfide (NaHS, 10 µmol/kg body weight/day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: D, L-propargylglycerine (CSE inhibitor)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normoxic conditions
Number of subjects: 100
Study: 20384610

Group type: EXPERIMENTAL
Intervention: Probiotic mixture (VSL#3)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 17993874

Group type: EXPERIMENTAL
Intervention: Calcium sulfate group (8 patients)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group (5 patients)
Number of subjects: 13
Study: 17325091

Group type: EXPERIMENTAL
Intervention: Counseling-based weaning intervention
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study: 14760111

Group type: EXPERIMENTAL
Intervention: Exemestane (E) 25 mg once daily
Number of subjects: 122

Group type: COMPARATOR
Intervention: Tamoxifen (T) 20 mg once daily
Number of subjects: 122
Study: 11142488

Group type: EXPERIMENTAL
Intervention: Verapamil (VER) 240 mg/day divided in 2 doses, from day 1 to day 28 of each cycle
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group (no VER)
Number of subjects: 99
Study: 9187418

Group type: EXPERIMENTAL
Intervention: Pravastatin 10 mg/day starting at day 3, increasing to 20 mg/day for 3 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1417492

Group type: EXPERIMENTAL
Intervention: Continuous suture (polyglyconate, size 0)
Number of subjects: 340

Group type: COMPARATOR
Intervention: Interrupted suture (polyglactin 910, size 1)
Number of subjects: 340
Study: 3883704

Group type: EXPERIMENTAL
Intervention: Self-monitoring of blood glucose (SMBG)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Formal education followed by SMBG
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Formal education only
Number of subjects: 37

Group type: COMPARATOR
Intervention: Reference group (no intervention)
Number of subjects: 37
Study: 30824961

Group type: EXPERIMENTAL
Intervention: Prophylactic intraperitoneal onlay mesh (Group A)
Number of subjects: 276

Group type: COMPARATOR
Intervention: No additional mesh strip (Group B)
Number of subjects: 276
Study: 29650336

Group type: EXPERIMENTAL
Intervention: Low-Intensity with Blood Flow Restriction (LIBFR)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Low-Intensity (LI)
Number of subjects: 18

Group type: COMPARATOR
Intervention: High-Intensity (HI)
Number of subjects: 18
Study: 27256153

Group type: EXPERIMENTAL
Intervention: SLIMMER intervention (10-month combined dietary and physical activity intervention)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 155
Study: 25275251

Group type: EXPERIMENTAL
Intervention: Olmesartan (OLM)
Number of subjects: 1513

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1513
Study: 22160628

Group type: EXPERIMENTAL
Intervention: Tai Chi Chuan (TCC)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard Support Therapy (SST)
Number of subjects: 21
Study: 20642391

Group type: EXPERIMENTAL
Intervention: Atomoxetine treatment at Week 8
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Atomoxetine treatment at 40 weeks
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Atomoxetine treatment at 8 weeks
Number of subjects: 267
Study: 17977190

Group type: EXPERIMENTAL
Intervention: Platelet gel treatment
Number of subjects: 50

Group type: COMPARATOR
Intervention: No platelet gel treatment (Control)
Number of subjects: 50
Study: 16380361

Group type: EXPERIMENTAL
Intervention: Parent education program presented on three audio CDs
Number of subjects: 846

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 846
Study: 12481953

Group type: EXPERIMENTAL
Intervention: Acupuncture for chronic headache
Number of subjects: 401

Group type: COMPARATOR
Intervention: Retrospective recruitment methods
Number of subjects: 401
Study: 9535315

Group type: EXPERIMENTAL
Intervention: Carbamazepine (450 mg at 150 mg three times per day, increased as needed)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Carbamazepine (after stopping, lactose placebo administered for 3 weeks)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Carbamazepine (second treatment)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Carbamazepine treatment
Number of subjects: 15
Study: 8593197

Group type: EXPERIMENTAL
Intervention: Stabilized stannous fluoride dentifrice (Crest Gum Care)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Regular Crest dentifrice (NaF)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Commercial dentifrice containing SnF2
Number of subjects: 16
Study: 2673476

Group type: EXPERIMENTAL
Intervention: Training in controlled breathing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study: 1106746

Group type: EXPERIMENTAL
Intervention: Terbutaline
Number of subjects: 21

Group type: COMPARATOR
Intervention: Rimiterol
Number of subjects: 21

Group type: COMPARATOR
Intervention: Combination of rimiterol and terbutaline
Number of subjects: 21
Study: 31958772

Group type: EXPERIMENTAL
Intervention: Plyometric Training (PT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 24
Study: 31682205

Group type: EXPERIMENTAL
Intervention: Autologous blood transfusion (ABT)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Pringle maneuver (PM)
Number of subjects: 125
Study: 28552931

Group type: EXPERIMENTAL
Intervention: Lower limb loading symmetry training based on follow-up posturography with adaptively modified visual biofeedback
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional rehabilitation program
Number of subjects: 60
Study: 26846795

Group type: EXPERIMENTAL
Intervention: Dextrose injections
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 30
Study: 24787499

Group type: EXPERIMENTAL
Intervention: High fat breakfast
Number of subjects: 24

Group type: COMPARATOR
Intervention: High protein breakfast
Number of subjects: 24

Group type: COMPARATOR
Intervention: High carbohydrate breakfast
Number of subjects: 24

Group type: COMPARATOR
Intervention: Balanced macronutrient breakfast
Number of subjects: 24
Study: 21822735

Group type: EXPERIMENTAL
Intervention: Child HRQoL reports
Number of subjects: 222

Group type: COMPARATOR
Intervention: Parent HRQoL reports
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Child and parent HRQoL agreement
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Social functioning
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Physical functioning
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: HRQoL domain scores
Number of subjects: 222
Study: 19700470

Group type: EXPERIMENTAL
Intervention: Irbesartan 150 mg/day followed by 300 mg/day on day 15
Number of subjects: 429

Group type: COMPARATOR
Intervention: Enalapril 10 mg/day followed by 20 mg/day on day 15
Number of subjects: 429
Study: 17479947

Group type: EXPERIMENTAL
Intervention: Atazanavir (400 mg per day or 300/100 mg per day with ritonavir)
Number of subjects: 419

Group type: COMPARATOR
Intervention: Comparator PI regimen
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Atazanavir
Number of subjects: 419
Study: 15543343

Group type: EXPERIMENTAL
Intervention: Cerivastatin 0.2 mg to 0.4 mg daily for 12 weeks
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Fenofibrate 250 mg daily for 12 weeks
Number of subjects: 38
Study: 12867500

Group type: EXPERIMENTAL
Intervention: Intracutaneous injection of endogenous PAR‐2 agonists
Number of subjects: 0

Group type: COMPARATOR
Intervention: Local antihistamines
Number of subjects: 0
Study: 10230458

Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy before irradiation
Number of subjects: 134

Group type: COMPARATOR
Intervention: Maintenance chemotherapy after irradiation
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Radiotherapy with contemporary positioning aids and individualized shielding techniques
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Radiotherapy with linear accelerators
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Radiotherapy with Cobalt machines
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Radiotherapy according to protocol guidelines
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Radiotherapy with a gap between treatment fields
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Acute neurotoxicity and skin reactions
Number of subjects: 134
Study: 8721775

Group type: EXPERIMENTAL
Intervention: Normal glucose tolerance
Number of subjects: 524

Group type: EXPERIMENTAL
Intervention: Impaired glucose tolerance
Number of subjects: 524

Group type: EXPERIMENTAL
Intervention: Newly detected diabetes
Number of subjects: 524
Study: 1826891

Group type: EXPERIMENTAL
Intervention: 5 mg ramipril
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 6294770

Group type: EXPERIMENTAL
Intervention: Post-cardiac arrest thiopental loading (30 mg/kg body wt)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 30623745

Group type: EXPERIMENTAL
Intervention: Alcoholic beverage consumption
Number of subjects: 78

Group type: COMPARATOR
Intervention: Nonalcoholic beverage consumption
Number of subjects: 78
Study: 29725846

Group type: EXPERIMENTAL
Intervention: 0.5% alpha-bisabolol mouthwash
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine + 0.5% alpha-bisabolol mouthwash
Number of subjects: 30

Group type: COMPARATOR
Intervention: 0.12% chlorhexidine mouthwash
Number of subjects: 30
Study: 28546260

Group type: EXPERIMENTAL
Intervention: Continuation group (azathioprine/prednisolone to 48 months)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Withdrawal group (withdraw azathioprine/prednisolone by 24 months)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: ANCA positivity at randomisation
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Continuation group
Number of subjects: 117

Group type: COMPARATOR
Intervention: Withdrawal group
Number of subjects: 117
Study: 26930181

Group type: EXPERIMENTAL
Intervention: Pramlintide
Number of subjects: 12
Study: 24509407

Group type: EXPERIMENTAL
Intervention: High-dose interferon-alpha2b (HDI) plus GM2-KLH/QS-1 (GMK)
Number of subjects: 794

Group type: COMPARATOR
Intervention: GMK alone
Number of subjects: 794

Group type: EXPERIMENTAL
Intervention: High-dose interferon-alpha2b (HDI)
Number of subjects: 794

Group type: COMPARATOR
Intervention: GMK (vaccine group)
Number of subjects: 794

Group type: EXPERIMENTAL
Intervention: HDI-induced autoimmunity
Number of subjects: 794
Study: 22491355

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 20
Study: 19171716

Group type: EXPERIMENTAL
Intervention: Autologous purged bone marrow transplantation (ABMT)
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Cis-retinoic acid (cis-RA)
Number of subjects: 379

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 379

Group type: COMPARATOR
Intervention: No further therapy
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: ABMT/cis-RA
Number of subjects: 379

Group type: COMPARATOR
Intervention: ABMT/no cis-RA
Number of subjects: 379

Group type: COMPARATOR
Intervention: Continuing chemotherapy/cis-RA
Number of subjects: 379

Group type: COMPARATOR
Intervention: Chemotherapy/no cis-RA
Number of subjects: 379
Study: 17141772

Group type: EXPERIMENTAL
Intervention: Position changes during colonoscope withdrawal (left lateral for the cecum to the hepatic flexure, supine for the transverse colon, and right lateral for the splenic flexure and the descending colon)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Left lateral position only (without position changes)
Number of subjects: 14
Study: 15860852

Group type: EXPERIMENTAL
Intervention: 10 x 3 Gy
Number of subjects: 297

Group type: COMPARATOR
Intervention: 2 x 8 Gy
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Both treatment arms
Number of subjects: 297
Study: 15002538

Group type: EXPERIMENTAL
Intervention: L-arginine-hydrochloride (18 g)
Number of subjects: 15
Study: 9113543

Group type: EXPERIMENTAL
Intervention: Limited tourniquet use for cementing time only
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Tourniquet use throughout the whole case
Number of subjects: 80

Group type: COMPARATOR
Intervention: No tourniquet use
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: All tourniquet groups
Number of subjects: 80
Study: 7510736

Group type: EXPERIMENTAL
Intervention: L-NMMA (3 mg/kg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 8
Study: 3315761

Group type: EXPERIMENTAL
Intervention: Hypoglycaemia induced by insulin-glucose clamp technique (insulin: 2.4 mU/kg/min + glucose at variable rate) after an overnight fast
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Hypoglycaemia induced by insulin-glucose clamp technique after 72 hours fasting
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Fasting (72 hours)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control study at normoglycaemia
Number of subjects: 8
Study: 30793929

Group type: EXPERIMENTAL
Intervention: Self-visualization (Group B, n = 165)
Number of subjects: 404

Group type: COMPARATOR
Intervention: No self-visualization (Group A, n = 239)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: First cystoscopy (males)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Third or more cystoscopy (males)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: First cystoscopy (females)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Third or more cystoscopy (females)
Number of subjects: 404
Study: 29504791

Group type: EXPERIMENTAL
Intervention: Home visiting intervention
Number of subjects: 1238

Group type: COMPARATOR
Intervention: Standard care condition
Number of subjects: 1238

Group type: EXPERIMENTAL
Intervention: Antenatal only (n = 154, 13.8%)
Number of subjects: 1238

Group type: EXPERIMENTAL
Intervention: Postnatal only (n = 272, 24.3%)
Number of subjects: 1238

Group type: EXPERIMENTAL
Intervention: Antenatal and postnatal (n = 220, 19.7%)
Number of subjects: 1238

Group type: EXPERIMENTAL
Intervention: No depressed mood on any assessment (n = 473, 42.3%)
Number of subjects: 1238
Study: 27345636

Group type: EXPERIMENTAL
Intervention: Obinutuzumab plus bendamustine
Number of subjects: 396

Group type: COMPARATOR
Intervention: Bendamustine monotherapy
Number of subjects: 396
Study: 24117102

Group type: EXPERIMENTAL
Intervention: Health Coaching (HC)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Formal Health Education (HE)
Number of subjects: 186
Study: 22419151

Group type: COMPARATOR
Intervention: Acarbose test formulation (2×50 mg)
Number of subjects: 40
Study: 18853144

Group type: EXPERIMENTAL
Intervention: Simple aspiration test
Number of subjects: 20

Group type: COMPARATOR
Intervention: Capnography
Number of subjects: 20
Study: 17766766

Group type: EXPERIMENTAL
Intervention: Pure self-help through written materials
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Augmented self-help (self-help augmented by five group sessions with a therapist)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Standard, therapist-led group therapy
Number of subjects: 224
Study: 15150679

Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEXA) 2.0 mg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Prednisolone (PRED) 12.5 mg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEXA)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Prednisolone (PRED)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Cortisol
Number of subjects: 14
Study: 11219635

Group type: EXPERIMENTAL
Intervention: Caffeinated coffee
Number of subjects: 0

Group type: COMPARATOR
Intervention: Decaffeinated coffee
Number of subjects: 0
Study: 9919256

Group type: EXPERIMENTAL
Intervention: Interactive video disk (IVD) system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Multidisciplinary team support and information
Number of subjects: 0
Study: 7820718

Group type: EXPERIMENTAL
Intervention: Heel puncture (Autolet II Clinisafe)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Incision (Tenderfoot 'preemie')
Number of subjects: 47
Study: 3277865

Group type: EXPERIMENTAL
Intervention: hCG (1500 IU three times at 2-day intervals from the day of ET)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control (no hCG support)
Number of subjects: 116
Study: 1562888

Group type: EXPERIMENTAL
Intervention: Distensive arthrography with intra-articular corticosteroids
Number of subjects: 45

Group type: COMPARATOR
Intervention: Nondistensive arthrography with intra-articular corticosteroids
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both treatments (distensive and nondistensive)
Number of subjects: 45
Study: 354827

Group type: EXPERIMENTAL
Intervention: alpha-methyldopa up to 500 mg b.i.d.
Number of subjects: 110

Group type: COMPARATOR
Intervention: metoprolol up to 200 mg b.i.d.
Number of subjects: 110
Study: 30423468

Group type: EXPERIMENTAL
Intervention: Desvenlafaxine (DVLX)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 28760403

Group type: EXPERIMENTAL
Intervention: Immediate androgen-deprivation therapy
Number of subjects: 293

Group type: COMPARATOR
Intervention: Delayed androgen-deprivation therapy
Number of subjects: 293
Study: 25681236

Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 30
Study: 23900457

Group type: EXPERIMENTAL
Intervention: Pegylated interferon-α2a
Number of subjects: 150
Study: 20821373

Group type: EXPERIMENTAL
Intervention: PST-OT (Problem-solving and Occupational Therapy intervention)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 31
Study: 19016254

Group type: EXPERIMENTAL
Intervention: Health Utilities Index (HUI)-III
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: AD-Related Quality of Life Scale (ADRQoL)
Number of subjects: 421
Study: 17074350

Group type: EXPERIMENTAL
Intervention: DHEAS concentrations in PCOS probands
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Sister-sister correlation of DHEAS levels
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Heritability (h²) of DHEAS levels
Number of subjects: 131
Study: 15080354

Group type: EXPERIMENTAL
Intervention: Chemomechanical Carisolv method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional mechanical method
Number of subjects: 0
Study: 11355097

Group type: EXPERIMENTAL
Intervention: 0.1% fluoride varnish application and professional tooth-cleaning, motivation and instruction in oral hygiene (T)
Number of subjects: 419

Group type: COMPARATOR
Intervention: Oral hygiene instruction and supervised toothbrushing once a year (C)
Number of subjects: 419